DALLAS, Nov. 07, 2025 (GLOBE NEWSWIRE) -- Arcadia Biosciences, Inc.® (NASDAQ:RKDA), a producer and marketer of innovative wellness products, today released its financial and business results for the third quarter of 2025.
"We are very pleased with our performance for the third quarter of 2025." said T.J. Schaefer, CEO of Arcadia. "Zola® coconut water revenues were flat year-over-year in the third quarter as we overlapped the initial sell-in to Zola's largest customer during the third quarter of 2024. However, on a year-to-date basis, Zola coconut water revenues have grown 26% and more than offset $700,000 in GLA sales in 2024 that did not occur in 2025. Additionally, our gross margins have now exceeded 30% for eleven consecutive quarters, SG&A expenses are at an all-time low and our cash management exceeded our expectations.
"In addition to our strong operating performance, we continue to own 2.7 million shares of Above Food Ingredients Inc. stock as a partial repayment of the $6 million principal amount of the note receivable related to the sale of GoodWheatTM assets in the second quarter of 2024 and are pursuing resolution of the remaining outstanding balance.
"Our pending business combination with Roosevelt Resources is still in progress," Schaefer continued, "but uncertainty exists regarding the timing due to several factors including the ongoing federal government shutdown that went into effect over a month ago. We continue to monitor events closely, but the shutdown is obviously a situation that is outside of our control."
Arcadia Biosciences, Inc. Financial Snapshot(Unaudited)
($ in thousands)
Three Months Ended September 30,
Nine Months Ended September 30,
2025
2024
Favorable/(Unfavorable)
2025
2024
Favorable/(Unfavorable)
$
%
$
%
Total revenues
1,302
1,537
(235
)
(15
%)
3,957
3,829
128
3
%
Total operating expenses
2,454
3,297
843
26
%
